Shelley R. Winn
20Patents
17h-index
16Co-inventors
74Inventor score
Filing activity: Nov 17, 1987 → Jan 25, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4892538A | In vivo delivery of neurotransmitters by implanted, encapsulated cells | Chemistry; Metallurgy | 392 | Expired |
| US5106627A | Neurological therapy devices | Chemistry; Metallurgy | 196 | Expired |
| US5858747A | Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers | Chemistry; Metallurgy | 145 | Expired |
| US5837234A | Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane | Human Necessities | 140 | Expired |
| US5639275A | Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules | Human Necessities | 137 | Expired |
| US5182111A | In vivo delivery of active factors by co-cultured cell implants | Chemistry; Metallurgy | 101 | Expired |
| US5776747A | Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer | Chemistry; Metallurgy | 98 | Expired |
| US5156844A | Neurological therapy system | Chemistry; Metallurgy | 85 | Expired |
| US5653975A | Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules | Human Necessities | 82 | Expired |
| US5795790A | Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 81 | Expired |
| US5656481A | Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules | Human Necessities | 64 | Expired |
| US5676943A | Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Human Necessities | 56 | Expired |
| US5935849A | Methods and compositions of growth control for cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 55 | Expired |
| US5833979A | Methods and compositions of growth control for cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 45 | Expired |
| US5853717A | Methods and compositions of growth control for cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 45 | Expired |
| US5840576A | Methods and compositions of growth control for cells encapsulated within bioartificial organs | Chemistry; Metallurgy | 45 | Expired |
| US5908623A | Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Human Necessities | 26 | Expired |
| US6264941A | Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | Human Necessities | 12 | Expired |
| US5843431A | Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation | Chemistry; Metallurgy | 4 | Expired |
| USRE35653E | In vivo delivery of neurotransmitters by implanted, encapsulated cells | General | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.